Shandong Wohua Pharmaceutical Co Ltd (002107) — Tangible Net Worth Ratio
Shandong Wohua Pharmaceutical Co Ltd (002107) has a Tangible Net Worth Ratio of 95.2% as of June 2026. This metric is calculated by deducting intangible assets (CN¥33.76 Million) from net assets (CN¥704.13 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Shandong Wohua Pharmaceutical Co Ltd (002107) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shandong Wohua Pharmaceutical Co Ltd Tangible Net Worth Ratio (2003–2025)
This chart shows how Shandong Wohua Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 23 annual periods from 2003 to 2025. As of June 2026, the ratio stands at 95.2%, reflecting net assets of CN¥704.13 Million with intangible assets of CN¥33.76 Million CNY. For live market cap and overall valuation, see Shandong Wohua Pharmaceutical Co Ltd (002107) market capitalisation.
Annual Tangible Net Worth Ratio for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025, covering 23 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Shandong Wohua Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.3% | CN¥732.64 Million | CN¥34.34 Million | CN¥977.37 Million | ▲ +0.2 pp |
| 2024 | 95.1% | CN¥722.93 Million | CN¥35.56 Million | CN¥985.73 Million | ▼ -0.5 pp |
| 2023 | 95.6% | CN¥833.48 Million | CN¥36.84 Million | CN¥1.14 Billion | ▲ +0.1 pp |
| 2022 | 95.4% | CN¥789.79 Million | CN¥36.03 Million | CN¥1.10 Billion | ▲ +1.3 pp |
| 2021 | 94.1% | CN¥929.26 Million | CN¥54.80 Million | CN¥1.16 Billion | ▲ +0.2 pp |
| 2020 | 93.9% | CN¥918.01 Million | CN¥55.69 Million | CN¥1.37 Billion | ▼ -1.8 pp |
| 2019 | 95.8% | CN¥775.15 Million | CN¥32.79 Million | CN¥1.01 Billion | ▼ -1.3 pp |
| 2018 | 97.0% | CN¥695.78 Million | CN¥20.70 Million | CN¥922.38 Million | ▲ +1.6 pp |
| 2017 | 95.4% | CN¥655.78 Million | CN¥29.99 Million | CN¥855.50 Million | ▲ +4.7 pp |
| 2016 | 90.7% | CN¥572.64 Million | CN¥53.32 Million | CN¥705.63 Million | ▲ +1.4 pp |
| 2015 | 89.2% | CN¥547.26 Million | CN¥58.88 Million | CN¥668.23 Million | ▼ -0.2 pp |
| 2014 | 89.4% | CN¥631.74 Million | CN¥66.74 Million | CN¥668.64 Million | ▼ -1.0 pp |
| 2013 | 90.4% | CN¥605.04 Million | CN¥58.09 Million | CN¥645.05 Million | ▲ +1.0 pp |
| 2012 | 89.4% | CN¥594.41 Million | CN¥63.25 Million | CN¥643.70 Million | ▼ -8.2 pp |
| 2011 | 97.5% | CN¥586.07 Million | CN¥14.48 Million | CN¥622.35 Million | ▲ +1.6 pp |
| 2010 | 96.0% | CN¥590.64 Million | CN¥23.91 Million | CN¥636.14 Million | ▼ -0.4 pp |
| 2009 | 96.4% | CN¥688.45 Million | CN¥25.00 Million | CN¥773.86 Million | ▲ +1.8 pp |
| 2008 | 94.6% | CN¥637.88 Million | CN¥34.51 Million | CN¥712.11 Million | ▲ +5.0 pp |
| 2007 | 89.6% | CN¥342.22 Million | CN¥35.64 Million | CN¥452.54 Million | ▲ +2.4 pp |
| 2006 | 87.2% | CN¥142.57 Million | CN¥18.30 Million | CN¥237.01 Million | ▲ +4.1 pp |
| 2005 | 83.1% | CN¥111.06 Million | CN¥18.77 Million | CN¥194.94 Million | ▲ +6.4 pp |
| 2004 | 76.7% | CN¥82.62 Million | CN¥19.25 Million | CN¥152.92 Million | ▲ +14.3 pp |
| 2003 | 62.4% | CN¥51.69 Million | CN¥19.43 Million | CN¥134.97 Million | — |